MK2866 - Pharmaqo Labs

Marketed under the research name MK-2866, Ostarine stands out among SARMs for its ability to selectively bind to androgen receptors in muscle and bone, resulting in anabolic effects without the harsh side effects seen in traditional anabolic agents. Originally investigated as a treatment for osteoporosis and muscle-wasting diseases, Ostarine has become popular among bodybuilders and athletes who want to build lean mass and improve bone density. Notably, it does not convert to estrogen, minimizing estrogenic side effects, and offers mild fat-burning benefits. It is often compared to lighter oral anabolic steroids for its muscle-boosting qualities without the risk of liver toxicity or water retention​​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about MK2866 by Pharmaqo Labs, consult with your doctor or healthcare professional.